Antiretroviral Drugs | ARVS | Gilead Sciences | Global Fund to Fight Malaria | Health | HIV Prevention
180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enough
South Africa’s first batch of the once-every-six-months HIV prevention shot, lenacapavir (LEN) — paid for with the country’s grant from the Global Fund to Fight Aids, TB and Malaria — will arrive soon, the health department says, although it’s slightly delayed. Government roll-out is set to start in government clinics within the next couple of…